Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · February 12, 2024

Outcomes of Treatment With Baricitinib in Patients With Moderate to Severe Alopecia Areata Aged 65 Years or Older

Clinical and Experimental Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical and Experimental Dermatology
Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib
Clin Exp Dermatol 2024 Jan 25;[EPub Ahead of Print], GT Tang, D Triwongwaranat, R Sinclair, S Joseph, S Eisman, D Rathnayake, V Varathan, L Trindade de Carvalho, B Bhoyrul

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading